On the recordMarch 10, 2014
If the United States were to follow the price control model, what would happen to patients' access to innovative treatments here in America as well as overseas?
Source
congress.govIf the United States were to follow the price control model, what would happen to patients' access to innovative treatments here in America as well as overseas?
Burr questions the effects of price controls on access to innovative treatments.
Share
More from Richard Burr
There is no Member that has defended the FDA more than this one and there is no Member in Congress that has tried to fix areas when they are broken than this one.
I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed.
I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.